Literature DB >> 12870780

Oncogenic transformation of normal enterocytes by overexpression of cyclin D1.

Diana Kazanov1, Itzhak Shapira, Marjorie Pick, Olga Kolker, Eliezer Liberman, Varda Deutsch, Loudmilla Strier, Hadas Dvory-Sobol, Talya Kunik, Nadir Arber.   

Abstract

Cyclin D1 plays an important role in the multi-step process of gastrointestinal tumorigenesis. We hypothesize that normal enterocytes over-expressing cyclin D1 will demonstrate a transformed phenotype. The nontumorigenic intestinal epithelial cell line, IEC-18, was transfected with the vector pMV7-CCND1, encoding cyclin D1. Three clones, with cyclin D1 levels similar to those seen in colon cancer cell lines, were further evaluated in comparison to the vector control cells. They proliferated faster and demonstrated anchorage-independent growth in soft agar, higher saturation density, and higher plating efficiency. When injected into nude mice, tumors were generated after 6-8 weeks. On the other hand these cells were more sensitive to induction of apoptosis. There was no change in the level of beta-catenin protein. In conclusion, cyclin D1 can act as an oncogene in vitro and in vivo, when produced in immortalized normal intestinal epithelial cells. This model may be useful for understanding the role and interrelationships of cyclin D1 in colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870780     DOI: 10.1023/a:1024138605802

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  55 in total

1.  Increased expression of the cyclin D1 gene in Barrett's esophagus.

Authors:  N Arber; C Lightdale; H Rotterdam; K H Han; A Sgambato; E Yap; H Ahsan; J Finegold; P D Stevens; P H Green; H Hibshoosh; A I Neugut; P R Holt; I B Weinstein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-06       Impact factor: 4.254

2.  Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.

Authors:  K Kitahara; W Yasui; H Yokozaki; S Semba; T Hamamoto; T Hisatsugu; E Tahara
Journal:  J Exp Ther Oncol       Date:  1996-01

3.  Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia.

Authors:  A I Robles; F Larcher; R B Whalin; R Murillas; E Richie; I B Gimenez-Conti; J L Jorcano; C J Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 4.  Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.

Authors:  H Strul; N Arber
Journal:  Isr Med Assoc J       Date:  2000-09       Impact factor: 0.892

5.  Increased cyclin D1 expression in chronic pancreatitis.

Authors:  M Kornmann; T Ishiwata; N Arber; H G Beger; M Korc
Journal:  Pancreas       Date:  1998-08       Impact factor: 3.327

6.  Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes.

Authors:  N Arber; T Sutter; M Miyake; S M Kahn; V S Venkatraj; A Sobrino; D Warburton; P R Holt; I B Weinstein
Journal:  Oncogene       Date:  1996-05-02       Impact factor: 9.867

7.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

8.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Authors:  M Shtutman; J Zhurinsky; I Simcha; C Albanese; M D'Amico; R Pestell; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.

Authors:  P Zhou; W Jiang; Y J Zhang; S M Kahn; I Schieren; R M Santella; I B Weinstein
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

10.  Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP.

Authors:  A Sewing; C Bürger; S Brüsselbach; C Schalk; F C Lucibello; R Müller
Journal:  J Cell Sci       Date:  1993-02       Impact factor: 5.285

View more
  3 in total

1.  Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.

Authors:  Tyler M Foley; Susan N Payne; Cheri A Pasch; Alex E Yueh; Dana R Van De Hey; Demetra P Korkos; Linda Clipson; Molly E Maher; Kristina A Matkowskyj; Michael A Newton; Dustin A Deming
Journal:  Mol Cancer Res       Date:  2017-02-09       Impact factor: 5.852

2.  Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer.

Authors:  Gregory Kouraklis; Stamos Theocharis; Panayiotis Vamvakas; Costas Vagianos; Andromahi Glinavou; Costas Giaginis; Crysoula Sioka
Journal:  World J Surg Oncol       Date:  2006-01-20       Impact factor: 2.754

3.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.